JP2006528199A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006528199A5 JP2006528199A5 JP2006521248A JP2006521248A JP2006528199A5 JP 2006528199 A5 JP2006528199 A5 JP 2006528199A5 JP 2006521248 A JP2006521248 A JP 2006521248A JP 2006521248 A JP2006521248 A JP 2006521248A JP 2006528199 A5 JP2006528199 A5 JP 2006528199A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- ethyl
- composition according
- formula
- purine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 5
- -1 hydroxy, amino Chemical group 0.000 claims 5
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical group C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 4
- 239000005977 Ethylene Chemical group 0.000 claims 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims 2
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 claims 2
- 102000009346 Adenosine receptors Human genes 0.000 claims 2
- 108050000203 Adenosine receptors Proteins 0.000 claims 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 206010030113 Oedema Diseases 0.000 claims 1
- 208000001647 Renal Insufficiency Diseases 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 230000003042 antagnostic effect Effects 0.000 claims 1
- 206010003119 arrhythmia Diseases 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 150000004985 diamines Chemical class 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000001475 halogen functional group Chemical group 0.000 claims 1
- 230000004217 heart function Effects 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 208000028867 ischemia Diseases 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 201000006370 kidney failure Diseases 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 201000008383 nephritis Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 230000008085 renal dysfunction Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48946903P | 2003-07-22 | 2003-07-22 | |
| PCT/US2004/023632 WO2005009445A1 (en) | 2003-07-22 | 2004-07-22 | A1 adenosine receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006528199A JP2006528199A (ja) | 2006-12-14 |
| JP2006528199A5 true JP2006528199A5 (enExample) | 2007-08-02 |
Family
ID=34102883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006521248A Pending JP2006528199A (ja) | 2003-07-22 | 2004-07-22 | A1アデノシン受容体拮抗薬 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7022710B2 (enExample) |
| EP (1) | EP1646390B1 (enExample) |
| JP (1) | JP2006528199A (enExample) |
| KR (1) | KR20060037383A (enExample) |
| AT (1) | ATE410168T1 (enExample) |
| CA (1) | CA2533402A1 (enExample) |
| DE (1) | DE602004017005D1 (enExample) |
| WO (1) | WO2005009445A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005047268A2 (en) * | 2003-11-10 | 2005-05-26 | X-Ceptor Therapeutics, Inc. | Substituted pyrimidine compositions and methods of use |
| US20080280926A1 (en) * | 2003-12-16 | 2008-11-13 | Palle Venkata P | Phosphodiesterase Inhibitors |
| US7795427B2 (en) * | 2006-02-14 | 2010-09-14 | New York University | Methods for inhibiting osteoclast differentiation, formation, or function and for increasing bone mass |
| ES2361886T3 (es) * | 2006-06-27 | 2011-06-24 | Cbt Development Limited | Profármacos adenosina acetil 2',3'-metilideno novedosos para uso como profármacos para agonistas del receptor adenosina. |
| WO2009052310A1 (en) * | 2007-10-16 | 2009-04-23 | Cv Therapeutics, Inc | A3 adenosine receptor antagonists |
| BRPI0909157A2 (pt) * | 2008-03-26 | 2015-11-24 | Advinus Therapeutics Private Ltd | compostos heterocíclicos como antagonistas de receptores de adenosina |
| DE102008039083A1 (de) * | 2008-08-21 | 2010-02-25 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 5-Aminopyrazole und ihre Verwendung |
| US20130109645A1 (en) | 2010-03-31 | 2013-05-02 | The united States of America,as represented by Secretary,Dept.,of Health and Human Services | Adenosine receptor agonists for the treatment and prevention of vascular or joint capsule calcification disorders |
| DE102011005232A1 (de) | 2011-03-08 | 2012-09-13 | AristoCon GmbH & Co. KG | Adenosin und seine Derivate zur Verwendung in der Schmerztherapie |
| WO2024105159A1 (en) * | 2022-11-16 | 2024-05-23 | University Of Zurich | Ligands of the m6a-rna readers |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19816857A1 (de) * | 1998-04-16 | 1999-10-21 | Boehringer Ingelheim Pharma | Neue unsymmetrisch substituierte Xanthin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US6545002B1 (en) * | 1999-06-01 | 2003-04-08 | University Of Virginia Patent Foundation | Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors |
| DK1208100T3 (da) * | 1999-08-31 | 2003-06-30 | Univ Vanderbilt | Selektive antagonister af A2B adenosinreceptorer |
| KR20020042248A (ko) * | 2000-11-30 | 2002-06-05 | 한가람 | 문장으로부터의 감정 인식 및 표시 방법과 시스템 |
| EP1401837B1 (en) * | 2001-06-29 | 2005-10-19 | Cv Therapeutics, Inc. | Purine derivatives as a2b adenosine receptor antagonists |
| WO2003006465A1 (en) * | 2001-07-13 | 2003-01-23 | Cv Therapeutics, Inc. | Partial and full agonist of a adenosine receptors |
| US7968523B2 (en) | 2001-07-23 | 2011-06-28 | Senesco Technologies, Inc. | Method for inducing apoptosis using apoptosis-specific EIF5-A |
| AU2002361374A1 (en) * | 2001-12-21 | 2003-07-09 | JSW-Research Forschungslabor GmbH% | Pyrazolyl-substituted triazoloquinoxalines |
-
2004
- 2004-07-22 WO PCT/US2004/023632 patent/WO2005009445A1/en not_active Ceased
- 2004-07-22 KR KR1020067001373A patent/KR20060037383A/ko not_active Ceased
- 2004-07-22 JP JP2006521248A patent/JP2006528199A/ja active Pending
- 2004-07-22 CA CA002533402A patent/CA2533402A1/en not_active Abandoned
- 2004-07-22 AT AT04778924T patent/ATE410168T1/de not_active IP Right Cessation
- 2004-07-22 US US10/897,047 patent/US7022710B2/en not_active Expired - Fee Related
- 2004-07-22 EP EP04778924A patent/EP1646390B1/en not_active Expired - Lifetime
- 2004-07-22 DE DE602004017005T patent/DE602004017005D1/de not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019031560A5 (enExample) | ||
| JP2006528199A5 (enExample) | ||
| JP2015520738A5 (enExample) | ||
| JP2012519179A5 (enExample) | ||
| JP2011509309A5 (enExample) | ||
| JP2017528506A5 (enExample) | ||
| RU2019120990A (ru) | Бициклические гетероарильные производные в качестве стимуляторов cftr | |
| JP2004523535A5 (enExample) | ||
| JP2019514945A5 (enExample) | ||
| JP2001525412A (ja) | Pdeiv阻害活性を有するプリン化合物および合成方法 | |
| JP2014526500A5 (enExample) | ||
| JP2010501478A5 (enExample) | ||
| JP2004517049A5 (enExample) | ||
| WO2005087729A1 (en) | 5-hydroxyindole-3-carboxylates derivatives and their use | |
| JP2004513882A5 (enExample) | ||
| JP2006501201A5 (enExample) | ||
| JP2011504935A5 (enExample) | ||
| CN102762542A (zh) | 一种新型抗真菌三唑衍生物 | |
| JP2008543860A5 (enExample) | ||
| JP2006507355A5 (enExample) | ||
| JP2002540102A (ja) | cGMPホスホジエステラーゼの縮合ピリドピリダジン阻害剤 | |
| JP2011516498A5 (enExample) | ||
| JP2013508382A5 (enExample) | ||
| WO2008117229A4 (en) | Muscarinic receptor antagonists | |
| JP2017522348A5 (enExample) |